Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries

Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries

<b>Background:</b> Chronic limb-threatening ischaemia can be a debilitating disease and may result in limb amputation if untreated. Atherosclerotic disease of the infra-popliteal arteries is particularly challenging to treat due to the small caliber of the vessels and the heavy burden of...

Full description

Bibliographic Details
Main Authors:	Elizabeth Lim, Ramon L. Varcoe
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Journal of Clinical Medicine
Subjects:	critical limb-threatening ischaemia drug-eluting stents endovascular bioresorbable scaffold
Online Access:	https://www.mdpi.com/2077-0383/13/6/1757

Similar Items

Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia
by: Marlon I. Spreen, et al.
Published: (2017-04-01)

Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium
by: Konstantinos Tigkiropoulos, et al.
Published: (2022-12-01)

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)

Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty vs. stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment
by: Paweł Latacz, et al.
Published: (2018-11-01)

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01)

Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View
by: Atsushi Sakamoto, et al.
Published: (2018-09-01)

Usefulness of off-label use of coronary drug-eluting stents as bailout for patients with critical limb ischemia and infrapopliteal arterial occlusive disease
by: Natarajan Sekar, et al.
Published: (2023-01-01)

Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis
by: Yan-di Wan, et al.
Published: (2022-09-01)

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial
by: Zacharenia Kallinikou, et al.
Published: (2016-01-01)

Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis
by: Khalid Changal, MD, et al.
Published: (2022-03-01)

Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials
by: Yong Liu, et al.
Published: (2022-10-01)

Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends
by: Lili Tan, et al.
Published: (2023-05-01)

One-year outcomes following primary stenting of infrapopliteal steno-occlusive arterial disease using a non-polymer sirolimus-eluting stent: Results from a prospective single-centre cohort study
by: Konstantinos Tigkiropoulos, et al.
Published: (2022-10-01)

BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial
by: Benjamin D. Hunt, et al.
Published: (2017-05-01)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
by: Brian Forrestal, et al.
Published: (2020-04-01)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Comparison of diagnostic accuracy of immediate angiography derived residual quantitative flow ratio after bioresorbable scaffold and drug eluting stent implantation
by: Zhengwei Li, et al.
Published: (2022-02-01)

Bioresorbable scaffolds: current concepts and future technology
by: Debabrata Dash, et al.
Published: (2022-08-01)

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)
by: Adrian Włodarczak, et al.
Published: (2024-03-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
by: T. M. Hommels, et al.
Published: (2020-10-01)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
by: Piotr Desperak, et al.
Published: (2020-04-01)

The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy
by: Francesco Nappi, et al.
Published: (2021-01-01)

Analysis of trends and prospects regarding stents for human blood vessels
by: Jeong Hee Lee, et al.
Published: (2018-03-01)

Nanoparticles-reinforced poly-l-lactic acid composite materials as bioresorbable scaffold candidates for coronary stents: insights from mechanical and finite element analysis
by: Toong, Daniel Wee Yee, et al.
Published: (2022)

Characteristics of lower-limb peripheral arterial disease in women
by: Marta Vasconcelos, et al.
Published: (2024-03-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
by: Jiang-Hua Si, et al.
Published: (2022-07-01)

Recent Advances in Manufacturing Innovative Stents
by: Natalia Beshchasna, et al.
Published: (2020-04-01)

Bioresorbable scaffolds: History and current knowledge
by: Min Ma, et al.
Published: (2016-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial
by: Ota Hlinomaz, et al.
Published: (2021-10-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)

Drug-Eluting Stents: Technical and Clinical Progress
by: Maciej Koźlik, et al.
Published: (2023-02-01)

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern
by: Takuya Tsujimura, et al.
Published: (2021-07-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario
by: Niklas F. Boeder, et al.
Published: (2021-06-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials
by: Julong Guo, et al.
Published: (2022-11-01)

Intravascular treatment of long segments of experimental peripheral arteries with multiple, serial, balloon-expandable, resorbable scaffolds
by: Rym El Khoury, MD, et al.
Published: (2022-01-01)